1. Home
  2. ABVX vs SPLP Comparison

ABVX vs SPLP Comparison

Compare ABVX & SPLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • SPLP
  • Stock Information
  • Founded
  • ABVX 2013
  • SPLP 1990
  • Country
  • ABVX France
  • SPLP United States
  • Employees
  • ABVX N/A
  • SPLP N/A
  • Industry
  • ABVX
  • SPLP Industrial Specialties
  • Sector
  • ABVX
  • SPLP Industrials
  • Exchange
  • ABVX Nasdaq
  • SPLP Nasdaq
  • Market Cap
  • ABVX 722.3M
  • SPLP 767.7M
  • IPO Year
  • ABVX N/A
  • SPLP N/A
  • Fundamental
  • Price
  • ABVX $9.50
  • SPLP $40.53
  • Analyst Decision
  • ABVX Strong Buy
  • SPLP
  • Analyst Count
  • ABVX 6
  • SPLP 0
  • Target Price
  • ABVX $36.50
  • SPLP N/A
  • AVG Volume (30 Days)
  • ABVX 82.3K
  • SPLP 1.6K
  • Earning Date
  • ABVX 09-09-2024
  • SPLP 11-08-2024
  • Dividend Yield
  • ABVX N/A
  • SPLP N/A
  • EPS Growth
  • ABVX N/A
  • SPLP 28.01
  • EPS
  • ABVX N/A
  • SPLP 9.74
  • Revenue
  • ABVX $9,676,417.00
  • SPLP $1,996,835,000.00
  • Revenue This Year
  • ABVX $31.67
  • SPLP N/A
  • Revenue Next Year
  • ABVX $1,189.66
  • SPLP N/A
  • P/E Ratio
  • ABVX N/A
  • SPLP $4.16
  • Revenue Growth
  • ABVX 100.87
  • SPLP 7.29
  • 52 Week Low
  • ABVX $8.75
  • SPLP $33.12
  • 52 Week High
  • ABVX $17.02
  • SPLP $42.58
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 34.50
  • SPLP 53.88
  • Support Level
  • ABVX $10.27
  • SPLP $36.10
  • Resistance Level
  • ABVX $10.79
  • SPLP $40.94
  • Average True Range (ATR)
  • ABVX 0.36
  • SPLP 0.84
  • MACD
  • ABVX -0.05
  • SPLP 0.11
  • Stochastic Oscillator
  • ABVX 8.16
  • SPLP 98.98

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About SPLP Steel Partners Holdings LP LTD PARTNERSHIP UNIT

Steel Partners Holdings LP operates in industrial products, energy, defense, supply chain management and logistics, banking, and youth sports industries. It operates in various segments including the Diversified Industrial segment comprised of manufacturers of engineered niche industrial products, including joining materials, tubing, building materials, performance materials, electrical products, cutting replacement products and services, and metallized films and packaging businesses; the Energy segment provides drilling and production services to the oil and gas industry and owns a youth sports business; the Financial Services segment consists of the operations of WebBank, a Utah chartered industrial bank, which engages in full range of banking activities.

Share on Social Networks: